×
For best experience we recommend to activate Javascript in your browser.
Recombinant OSMR (Vixarelimab Biosimilar) antibody
Reactivity: Human
FACS, BLI, ELISA, Func, SPR
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
Product Details anti-OSMR (Vixarelimab Biosimilar) Antibody
(hide)
Target
See all OSMR (Vixarelimab Biosimilar) products
OSMR (Vixarelimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for OSMR (Vixarelimab Biosimilar) antibodies
Human
Expression System
CHO Cells
Clonality
All clonalities for OSMR (Vixarelimab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for OSMR (Vixarelimab Biosimilar) antibodies
This OSMR (Vixarelimab Biosimilar) antibody is un-conjugated
Application
Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), ELISA, Functional Studies (Func), Surface Plasmon Resonance (SPR)
Purpose
Anti-OSMR Reference Antibody (vixarelimab)
Characteristics
Anti-OSMR Reference Antibody (vixarelimab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hulambda. It has a predicted MW of 145.5 kDa.
Purity
>95 %
Isotype
IgG4SP
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Lyophilized
Concentration
1 mg/mL
Buffer
25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
Storage
4 °C,-80 °C
Storage Comment
+4°C,-80°C
Target Details for OSMR (Vixarelimab Biosimilar)
(hide)
Target
OSMR (Vixarelimab Biosimilar)
Abstract
OSMR (Vixarelimab Biosimilar) Products
Target Type
Biosimilar
Molecular Weight
145.5 kDa
UniProt
Q99650
Recently viewed
(hide)